Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy
October 6 University
90 participants
Aug 24, 2023
INTERVENTIONAL
Conditions
Summary
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Eligibility
Inclusion Criteria1
- unilateral acute facial palsy of no identifiable cause
Exclusion Criteria11
- Recurrent facial Bell's palsy
- Pregnancy
- Diabetes
- Epilepsy
- Severe hypertension,
- Renal or hepatic disease,
- Gastric or duodenal ulcer
- presence of acute otitis media or ipsilateral chronic otitis
- Recent head injury,
- psychiatric disease
- If there is any contraindications for corticosteroids
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
prednisolone 60mg tablet once daily for 5 days then tapering dose
intramuscular Cerebrolysin 10 mg daily for 3 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05821075